Location History:
- Branford, CT (US) (2021)
- New Haven, CT (US) (2020 - 2022)
Company Filing History:
Years Active: 2020-2025
Title: **The Innovative Contributions of Sean MacKay**
Introduction
Sean MacKay, an accomplished inventor residing in New Haven, CT, is known for his significant contributions to the field of immunotherapeutics. With a total of 7 patents to his name, MacKay's work is at the forefront of biomedical innovation, particularly in the analysis and application of cellular therapies.
Latest Patents
Among his latest innovations, MacKay has developed groundbreaking patents focusing on the multiplexed analysis of cellular and other immunotherapeutics. One of his notable patents discloses methods for identifying a secretome from subject cells within heterogeneous cell populations. This method is particularly applicable when subject immune cells, such as T-cells, interact with target cancer cells or stimulatory agents. His work paves the way for identifying cells that are safe and efficacious for cellular therapies, including adoptive CAR T-cell therapies.
Another significant patent involves the analysis and screening of cell secretion profiles. This invention includes apparatus, methods, and software designed for biological screening and analysis, utilizing an instrument platform capable of detecting a wide variety of cell-based secretions and expressed proteins. This innovative platform is configured for simultaneous multiplexed detection, allowing for the highly parallelized evaluation of numerous discrete samples.
Career Highlights
MacKay currently lends his expertise to Isoplexis Corporation, where he contributes to the development of pioneering technologies in the life sciences. His work aims to enhance therapeutic strategies and improve patient outcomes through advanced cellular analysis and therapeutic design.
Collaborations
During his career, Sean MacKay has had the opportunity to collaborate with notable professionals in his field, including Patrick Paczkowski and Sean McCusker. These partnerships have fostered an environment of innovation and have propelled advancements in the understanding of cellular therapies.
Conclusion
Through his innovative patents and collaborations, Sean MacKay has made substantial contributions to the realm of immunotherapy and cellular analysis. His work continues to impact the field, advancing our capabilities to understand and treat complex diseases, thereby shaping the future of therapeutic development.